Evaluation of the effect of Boswellia serrata Roxb. ex Colebr. oleogum resin on sperm motility in men with sperm motility defects (asthenospermia)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140817018828N7

Enrollment

Registered

2020-08-24

Start date

2020-08-24

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenospermia. asthenospermia

Interventions

Intervention 1: Control group: This group receives 2 placebo capsules containing cellulose per day for 84 days. In addition to this treatment, patients take 1 tablet of folic acid 5 mg daily. Interven

Eligibility

Sex/Gender

Male

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Willingness to cooperate At least one year has passed since the decision to have a child and not to use contraceptives Idiopathic asthenospermia according to WHO criteria

Exclusion criteria

Exclusion criteria: Men with infertility with a specific cause (such as hormonal disorders) Infertility of the wife Drug and alcohol use Having underlying diseases such as diabetes, kidney disease (creatinine more than 2 times), chronic liver disease Taking antioxidant supplements in the last three months

Design outcomes

Primary

Measure	Time frame
Sperm motility. Timepoint: Before the intervention and 84 days after taking the drug or placebo. Method of measurement: Sperm test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlimohamad Ranjbar Jamal abadi

Yazd University of Medical Sciences

amranjbar@razi.tums.ac.ir+98 35 3820 3419

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026